tiprankstipranks
Trending News
More News >
BriaCell Therapeutics Corp (TSE:BCT)
TSX:BCT
Canadian Market

BriaCell Therapeutics (BCT) Financial Statements

Compare
79 Followers

BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently C$24.12M. The company's EPS TTM is C$-3.311; its P/E ratio is ―; BriaCell Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21Sep 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ -20.49KC$ -19.39KC$ -19.44KC$ -18.74K
Operating Income-C$ -23.27MC$ -15.29MC$ -6.97MC$ -3.94M
EBITDA-C$ -22.37MC$ -34.05MC$ -6.95MC$ -3.96M
Net Income-C$ -20.30MC$ -11.58MC$ -2.90MC$ 1.39M
Balance Sheet
Cash & Short-Term InvestmentsC$ 862.09KC$ 21.25MC$ 41.04MC$ 57.27MC$ 19.46K
Total AssetsC$ 5.87MC$ 27.16MC$ 42.58MC$ 58.04MC$ 478.31K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 25.99KC$ 228.75K
Net DebtC$ -862.09KC$ -21.25MC$ -41.04MC$ -57.24MC$ 209.29K
Total LiabilitiesC$ 8.56MC$ 30.94MC$ 32.25MC$ 782.24KC$ 3.77M
Stockholders' EquityC$ -2.38MC$ -3.78MC$ 10.33MC$ 57.26MC$ 0.00
Cash Flow
Free Cash FlowC$ -24.58MC$ -23.74MC$ -12.48MC$ -7.75M-
Operating Cash FlowC$ -24.13MC$ -23.74MC$ -12.48MC$ -7.75M-
Investing Cash FlowC$ -681.80KC$ 0.00C$ 0.00C$ 0.00-
Financing Cash FlowC$ 4.42MC$ 3.95MC$ -3.74MC$ 65.00MC$ 1.08M
Currency in CAD

BriaCell Therapeutics Earnings and Revenue History

BriaCell Therapeutics Debt to Assets

BriaCell Therapeutics Cash Flow

BriaCell Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis